Osmind

Osmind, headquartered in San Francisco, California, operates within the healthcare industry, specifically focusing on Healthcare IT. The company, with a team of 55 employees, provides an innovative electronic health record (EHR) technology tailored for interventional treatment workflows in neuropsychiatric clinics. This technology supports a range of treatments including transcranial magnetic stimulation, ketamine, SPRAVATO®, psychedelic medicine, and electroconvulsive therapy. Osmind’s platform is designed to enhance patient engagement and includes features such as journaling tools, seamless charting, outcomes tracking, and assistance with health plan reimbursement. Additionally, the platform integrates telehealth capabilities through Zoom and offers an easy setup and user interface. Osmind is actively involved in mental health research, conducting studies using proprietary real-world data and machine learning, and has collaborated with prestigious institutions like Stanford University School of Medicine. Their research has been featured in the Journal of Affective Disorders and other notable publications. The company has been recognized by CB Insights and top venture capitalists as one of the most innovative and promising in the digital health sector. Osmind also maintains a comprehensive blog on mental health treatment and research, and provides a demo booking option on their website, facilitated by Chili Piper integration.